210 related articles for article (PubMed ID: 14594113)
1. Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.
Gambineri A; Pagotto U; Tschöp M; Vicennati V; Manicardi E; Carcello A; Cacciari M; De Iasio R; Pasquali R
J Endocrinol Invest; 2003 Jul; 26(7):629-34. PubMed ID: 14594113
[TBL] [Abstract][Full Text] [Related]
2. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
[TBL] [Abstract][Full Text] [Related]
3. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
[TBL] [Abstract][Full Text] [Related]
6. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
[TBL] [Abstract][Full Text] [Related]
7. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
Gambineri A; Patton L; Vaccina A; Cacciari M; Morselli-Labate AM; Cavazza C; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2006 Oct; 91(10):3970-80. PubMed ID: 16868063
[TBL] [Abstract][Full Text] [Related]
8. Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
Kos-Kudła B; Małecka-Mikosz O; Foltyn W; Ostrowska Z; Kudła M; Mazur B
Neuro Endocrinol Lett; 2006 Dec; 27(6):763-7. PubMed ID: 17187005
[TBL] [Abstract][Full Text] [Related]
9. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
[TBL] [Abstract][Full Text] [Related]
10. Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome.
Sahin I; Serter R; Karakurt F; Demirbas B; Guler S; Culha C; Taskapan C; Aral Y
Horm Res; 2003; 60(5):232-6. PubMed ID: 14614228
[TBL] [Abstract][Full Text] [Related]
11. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
[TBL] [Abstract][Full Text] [Related]
12. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy restores normal ghrelin in hypogonadal men.
Pagotto U; Gambineri A; Pelusi C; Genghini S; Cacciari M; Otto B; Castañeda T; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2003 Sep; 88(9):4139-43. PubMed ID: 12970277
[TBL] [Abstract][Full Text] [Related]
15. Circulating ghrelin levels in patients with polycystic ovary syndrome.
Schöfl C; Horn R; Schill T; Schlösser HW; Müller MJ; Brabant G
J Clin Endocrinol Metab; 2002 Oct; 87(10):4607-10. PubMed ID: 12364442
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
17. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
Guido M; Romualdi D; De Marinis L; Porcelli T; Giuliani M; Costantini B; Lanzone A
Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
[TBL] [Abstract][Full Text] [Related]
18. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
[TBL] [Abstract][Full Text] [Related]
19. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women.
Fox JH; Licholai T; Green G; Dunaif A
Fertil Steril; 1993 Dec; 60(6):994-1000. PubMed ID: 8243706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]